Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

HIV-1 infection of human monocyte-derived dendritic cells with and without the integrase inhibitor, Raltegravir

ABSTRACT: HIV-1 infection of human monocyte-derived dendritic cells with and without the integrase inhibitor, Raltegravir

PROVIDER: PRJNA391481 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

HIV-1 infection of human monocyte-derived dendritic cells with and without the integrase inhibitor, Raltegravir (ATAC-Seq).

Project description:Myeloid dendritic cells (DCs) have the innate capacity to sense pathogens and orchestrate immune responses. However, DCs do not mount efficient immune responses to HIV-1, due to potent restriction at the level of reverse transcription. Here, we uncover that when reverse transcription is allowed to proceed, DCs detect HIV-1 in distinct phases, before and after integration. Blocking integration suppressed, but did not abolish, activation of the transcription factor, IRF3, interferon responses, and DC maturation. The cytoplasmic DNA sensor, cGAS, and the E3 ligase, TRIM5, were both required for these responses. Consistent with two stages of innate activation, HIV-1 altered host chromatin accessibility before and after integration. Our studies support the hypothesis that HIV-1 replication increases the amount of material available for sensing and that cGAS signaling can be tuned by discrete inflammatory inputs to drive DC maturation.

2018-03-22 | GSE100376 | GEO

HIV-1 infection of human monocyte-derived dendritic cells with and without the integrase inhibitor, Raltegravir (gene expression).

2018-03-22 | GSE100374 | GEO

Molecular targets of HIV integrase inhibitor, MK-2048, on ATL cells

Project description:Adult T-cell Leukemia (ATL) is a highly chemoresistant malignancy of peripheral T lymphocytes, associated with retrovirus human T-cell leukemia virus type I (HTLV-1). To elucidate the complex molecular mechanism of anti-Growth effect of the HIV integrase inhibitor, MK-2048 in ATL cells, we attempted to perform gene expression profiling.

2020-01-01 | GSE113265 | GEO

Coinfection of monocyte derived dendritic cells with HSV2 and HIV

Project description:Coinfection of monocyte derived dendritic cells with HSV2 and HIV

2019-11-19 | GSE140612 | GEO

CLIP-seq analysis of integrase-RNA interactions

2016-08-25 | GSE83588 | GEO

Transcriptome profiling of alphaherpesvirus-infected cells treated with the HIV-integrase inhibitor raltegravir reveals profound and specific alterations in host transcription.

Project description:Purpose: To study the effects of raltegravir treatment for corneal cells on host gene expression during FHV-1 infection and in uninfected cells. Method: For examination of effects in infected cells, corneal cells were infected with FHV-1 for 2 hours and treated with raltegravir or DMSO for 2 h. For examination of effects in uninfected cells, corneal cells were infected with FHV-1 for 2 h. Data was analyzed using a standard pipeline. Follow up of results were done with SYBR green based qPCR and functional assays where relevant. Results: In infected cells, we identifed 399 differentially expressed genes following raltegravir therapy. Many of these genes had functions as anti-angiogenic factors and in metabolic pathways. In contrast, in uninfected cells, only 27 genes were identified as differentially regulated by raltegravir, with little overlap with those modulated during infection and little shared biological functions. This indicates that raltegravir is unlikely to induce side effects in vivo. Conclusion: Our study represents the first, to our knowledge, use of RNAseq technology to study the effects of an antiviral on host gene expression during a virus infection. We conclude that such methodology will be useful in future studies to identify bystander effects of drug treatment.

2018-06-13 | GSE109806 | GEO

CLIP-seq analysis of integrase-RNA interactions

Project description:Integrase CLIP-seq experiments were conducted on wild-type and eccentric HIV-1 virions generated in the presence of allosteric integrase inhibitors and IN K264/266A and R269/K273A mutations Integrase CLIP-seq experiments were conducted by immunoprecipitation of integrase-RNA complexes from fully formed mature and eccentric virus particles. Libraries of RNA molecules bound by integrase were generated and sequenced by Illumina Hi-Seq2000 and 2500 platforms.

2016-08-25 | E-GEOD-83588 | biostudies-arrayexpress

HIV integrase deep sequencing.

Project description:Identification of minority resistance mutations in the HIV-1 integrase gene using Next Generation Sequencing

| PRJEB9552 | ENA

HIV-1 infection of human monocyte-derived dendritic cells with and without the integrase inhibitor, Raltegravir

Project description:This SuperSeries is composed of the SubSeries listed below.

2018-03-22 | GSE100377 | GEO

Molecular targets of HIV integrase inhibitor, MK-2048, on ATL cells

Project description:Molecular targets of HIV integrase inhibitor, MK-2048, on ATL cells

| PRJNA450607 | ENA